Developing new antibiotics to fight Salmonella infections

BLRD Research Career Scientist Award Application

NIH-funded research VA Eastern Colorado Health Care System · NIH-10948076

This study is looking into how Salmonella bacteria become resistant to antibiotics so that researchers can create new treatments to help people who are sick with Salmonella infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Eastern Colorado Health Care System NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project IDNIH-10948076 on NIH RePORTER

What this research studies

This research focuses on understanding how Salmonella bacteria become resistant to antibiotics and aims to develop new antibiotics to combat these infections. The team will investigate specific proteins and molecules that regulate the bacteria's ability to survive and cause disease. By studying the mechanisms of bacterial virulence and antibiotic resistance, the researchers hope to create effective treatments for patients suffering from Salmonella infections. This work is crucial given the rising rates of multidrug-resistant Salmonella worldwide.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have been diagnosed with Salmonella infections, particularly those with antibiotic-resistant strains.

Not a fit: Patients with infections caused by non-Salmonella pathogens or those who do not have antibiotic-resistant infections may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel antibiotics that effectively treat multidrug-resistant Salmonella infections, potentially saving lives.

How similar studies have performed: Previous research has shown promise in developing antibiotics targeting bacterial transcription mechanisms, indicating potential success for this approach.

Where this research is happening

Aurora, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAlzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.